Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer-Reference-Cited by-同舟云学术

Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer

Published:1997-01 Issue:1 Volume:8 Page:57-64
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fetscher S.,Brugger W.,Engelhardt R.,Kanz L.,Hasse J.,Frommhold H.,Wenger M.,Lange W.,Mertelsmann R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/8/1/57/19480173/8-1-57.pdf

Reference81 articles.

1. Palliative chemotherapy for non-small cell lung cancer;Adelstein;Semin Oncol,1995

2. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer Mature results of Southwest Oncology Group phase II study 8805;Albain;J Clin Oncol,1995

3. Combination chemotherapy with vinorelbine, ifosfamide and cisplatin: A phase II study in stage IIIB/IV non-small-cell lung cancer;Baldini;Semin Oncol,1994

4. Quality-of-life and cost-effectiveness assessment in lung cancer;Bergman;Curr Opin Oncol,1995

5. Combined modality therapy in non-small cell lung cancer;Blanke;Curr Opin Oncol,1995

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term Results of a Pilot Study on an Intensive Induction Regimen for Unresectable Stage III Non-Small-Cell Lung Cancer;Tumori Journal;2010-01

2. Solid tumors in adults;Hematopoietic Stem Cell Transplantation in Clinical Practice;2009

3. Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer;Bone Marrow Transplantation;2007-08-13

4. Small-cell lung cancer;The Lancet;2005-10

5. Relevance of high-dose chemotherapy in solid tumours;Cancer Treatment Reviews;2005-05